Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NF-kappaB activation.

E Abraham1

  • 1Department of Medicine, University of Colorado Health Sciences Center, Denver, USA.

Critical Care Medicine
|May 12, 2000
PubMed
Summary
This summary is machine-generated.

Nuclear factor kappa B (NF-kappaB) activation is central to critical illness inflammation. Understanding NF-kappaB regulation is key for developing therapies to prevent organ dysfunction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Near-infrared-terahertz hyper-Raman spectroscopy of an excited silicon surface.

The Journal of chemical physics·2024
Same author

Accessible and reliable neurometric testing in humans using a smartphone platform.

Scientific reports·2023
Same author

Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Ultrafast, broadband and tunable terahertz reflector and neutral density filter based on high resistivity silicon.

Optics express·2022
Same author

Mental health improvements after elective spine surgery: a Canadian Spine Outcome Research Network (CSORN) study.

The spine journal : official journal of the North American Spine Society·2021
Same author

Erratum to 'Patients' expectations of spine surgery for degenerative conditions: results from the Canadian Spine Outcomes and Research Network (CSORN)'. [Spine J. 2020;20(3):399-408].

The spine journal : official journal of the North American Spine Society·2020
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Attracting Emergency Medicine Graduates to Surgical Critical Care Training Programs.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Beyond a Snapshot: Tracking Family Prognostic Expectations in the ICU.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure: Beware of Potential Confounders.

Critical care medicine·2026
See all related articles

Area of Science:

  • Molecular Biology
  • Immunology
  • Critical Care Medicine

Background:

  • Nuclear factor kappa B (NF-kappaB) binding sites are found in promoters of key inflammatory mediators in critical illnesses.
  • Increased NF-kappaB activation correlates with enhanced expression of these mediators, suggesting a central role in multiple organ dysfunction.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of NF-kappaB activation in the context of critical illness.
  • To identify potential therapeutic targets for preventing or mitigating acute inflammatory injury.

Main Methods:

  • Review of literature on NF-kappaB signaling pathways.
  • Analysis of NF-kappaB's role in cytokine and mediator expression.
  • Examination of regulatory steps including I kappaB interaction and nuclear translocation.

Related Experiment Videos

Main Results:

  • NF-kappaB is sequestered in the cytoplasm by I kappaB.
  • Activation involves I kappaB phosphorylation, ubiquitination, and proteolysis, enabling NF-kappaB nuclear translocation.
  • Transcriptional activity is modulated by I kappaB levels, NF-kappaB subunit composition, and CBP binding competition.

Conclusions:

  • NF-kappaB plays a pivotal role in the immunoregulatory responses driving critical illness-related inflammation and organ dysfunction.
  • Targeting NF-kappaB regulatory steps offers a promising strategy for future therapeutic interventions.